Killer artificial antigen-presenting cells treating skin allograft rejection and its impact on the overall immune function in mice model

Miao-chen LI,Wei WANG,Xiao-e LI,Kun FANG,You WU,Ning GU,Chuan-Iai SHEN
DOI: https://doi.org/10.3969/j.issn.1671-6264.2015.04.002
2015-01-01
Abstract:Objective: To study the therapeutic effect for skin allograft rejection of killer artificial antigen-presenting cells( KaAPC) and its impact on the overall immune function in mice model.Methods: KaAPC were prepared by co-coupling H-2Kb antigen and anti-Fas monoclonal antibody onto the biodegradable polylactic-co-glycolic acid ( PLGA) microspheres, and then were administered intravenously into BALB/c mice ( H-2Kd ) that had previously been grafted with skin squares from C57BL/6 mice (H-2Kb).Tumor cell challenge and third-party mixed lymphocyte culture were used to assess the general immune functions of host.Results:KaAPC microspheres had the correct phenotype as verified by FACS;the skinallograft survival was prolonged significantly(P<0.000 1) after treatment with KaAPC;the proliferation of recipient T cells against the third-party splenocytes and the defense to tumor did not apparently decreased after treatment with KaAPC in therapy mice.Conclusion:The KaAPC have ability to inhibit skin allograft rejection in mice model, without impairment of host overall immune function.
What problem does this paper attempt to address?